company insight

Gerteis® – More than three decades passion for Roller Compaction

Gerteis Maschinen + Processengineering AG is a Swiss-based company that has established itself as world leader in the field of premium roller compactors. The company’s products and services cover all aspects of dry granulation processes, with unparalleled experience in this field built up since the company was founded in 1986.

Achieving compliance with local requirements can be a tough deal and an unexpected challenge sometimes

Your Dry Granulation Experts!

The success of the company can be ascribed to a variety of reasons, not least of which are the values at the core of the enterprise; the reliability, sustainability and quality of its machines are the foundation of the company's good reputation. Partnered with a dedication to service and customer satisfaction, Gerteis® is committed to maintaining the level of excellence it has cultivated so far.


Looking back at the earliest years when the company was still a one-man-business, Paul Gerteis remembers the challenges of starting off in a field that already had long-established enterprises competing for a share in the market. His background in sales of pharmaceutical equipment provided Gerteis with an in-depth knowledge of the needs of his future customers and in what he calls a lucky coincidence he found a way to make roller compaction a viable and advantageous option for processing most substances. The development of the patented Gerteis compaction technology was only the first step in founding what is now a market-leading company. Customers had to be won and they were impressed by the numerous unique benefits offered by the Gerteis® roller compaction systems. It is in these early days that Paul Gerteis set the standard for the excellent customer service that the company still prides itself on today. “It was my personal commitment to serving the customer to the best of my ability that opened the doors to many of the companies we still supply today,” says Paul Gerteis in an interview. Word of mouth helped him establish his company which has seen a continuous growth since its founding days.

Visit Gerteis at Achema 2018!

Choosing a Gerteis® roller compactor is a long-term investment with some machines having been in use for more than two decades. This longevity is coupled with a high sustainability since the dry granulation process is a very energy-efficient and fast method to achieve a homogeneous granulate. The patented roller technology employed by all Gerteis compactors allows for a uniform consistency in the product and handles all products with the utmost care during the compaction process. Thanks to WIP (Wash in Place) and CIP (Clean in Place) systems available as part of most compactor series, down time needed for cleaning can be kept to a minimum. The CIP system in combination with Gerteis’ bespoke containment system ensures a high level of protection for the operators against dangerous substances.


To ensure the best possible service Gerteis is in constant exchange with engineers, scientists and suppliers to remain up-to-date with current trends, requirements and innovations. This translates into reliable expertise in finding optimal solutions for their customers' production issues and increasing the existing output by optimising processes. Their customised designs are tailored to the needs of each customer and in-house training courses assure that operators are capable of handling and servicing the machines. Thanks to regional partners Gerteis is able to resolve maintenance issues and problems quickly and efficiently.


2018 will be an exciting year for Gerteis with a first outstanding customer events taking place in June. From 11 to 15 June trade fair ACHEMA takes place in Frankfurt, Germany, an excellent opportunity to meet with industry’s key stakeholders in R&D, production and engineering to discuss new solutions and share insights.

Three roller compactors will be placed on booth to represent Gerteis’ abilities to serve different customer requirements and allowing visitors to get a hands-on experience:

  • MINI-PACTOR®: A high containment roller compactor designed for R&D applications and the most stringent GMP requirements, utilizing a unique feed and force control system, large diameter rolls and a superior punch & die designed compaction roll system. The Mini Pactor® line is capable of producing from 10 grams of product up to 100kg/hr continuous production.
    New control features allowing language switch, giving global flexibility to multinational enterprises.
  • MACRO-PACTOR®: The choice for full production! A high containment roller compactor using the technical features of the Mini-Pactor with a production capacity of up to 400 kilograms an hour, again while maintaining OEL down to 3µg/m³ as standard.
  • Polygran®: The Polygran® compactor can produce up to 300kg/hr by using similar control systems as the larger Pactor® Series, different roller surfaces and easily interchangeable screens for maximized output efficiency.

Attendees are cordially invited to visit the Gerteis stand in Hall 3.0 Booth D25 where they can observe the roller compactors in action, running dry powder processing demonstrations throughout the event.

Share this article

Go to article: Home | The Dawn of Big DataGo to article: EditorialGo to article: Scandinavian Health Ltd. Company InsightGo to article: Scandinavian Health Ltd.Go to article: ContentsGo to article: Daiichi JitsugyoGo to article: How will Amazon's acquisition of online pharmacy business PillPack disrupt the pharmaceutical industry? Go to article: HOF Sonderanlagenbau Company InsightGo to article: HOF SonderanlagenbauGo to article: Fentanyl: where did it all go wrong?Go to article: NSFGo to article: Komtur Pharmaceuticals Company InsightGo to article: Komtur PharmaceuticalsGo to article: Turning up the heat on nano researchGo to article: TSS Company InsightGo to article: TSS ABGo to article: MedelpharmGo to article: Cracking the mystery of Alzheimer's diseaseGo to article: Röchling Medical NeuhausGo to article: International Cannabis and Cannabinoid Institute (ICCI) Company InsightGo to article: International Cannabis and Cannabinoid Institute (ICCI)Go to article: Where are the world's pharma manufacturing hotspots?Go to article: Gerteis Company InsightGo to article: GerteisGo to article: ZenatekGo to article: How India’s use of unapproved antibiotics could undermine global healthGo to article: Novo Nordisk PharmatechGo to article: Phoenix Company InsightGo to article: PhoenixGo to article: CRISPR: a seismic shift in gene editingGo to article: CBDepot Company InsightGo to article: CBDepotGo to article: Is the UK’s drug evaluation system in need of an overhaul?Go to article: Nelson Labs Company InsightGo to article: Nelson LabsGo to article: Centaur Clinical | Company InsightGo to article: Centaur ClinicalGo to article: Opening up the Chinese drug marketGo to article: Finnair Cargo | Company InsightGo to article: Finnair CargoGo to article: Immunising against opioids – could a vaccine solve the crisis? Go to article: Molnar Company InsightGo to article: MolnarGo to article: PharmasolGo to article: The next generation of antimalarials Go to article: Oncology Therapeutic Development Company InsightGo to article: Oncology Therapeutic DevelopmentGo to article: Pharma Support Services Company InsightGo to article: Pharma Support ServicesGo to article: The People vs Big Pharma: tackling the industry’s trust issuesGo to article: G.F.Go to article: Pfanstiehl Company InsightGo to article: PfanstiehlGo to article: Amazon and PillPack: an unstoppable pharmacy force?Go to article: BEAGo to article: Buchi Labortechnik AG Company InsightGo to article: Buchi Labortechnik AGGo to article: Is the microbiome as important for precision medicine as genetics?Go to article: Medical HempGo to article: Senn ChemicalsGo to article: Senn ChemicalsGo to article: Niconex Medical LtdGo to article: HPV vaccines: a decade of progressGo to article: Med-Script AssociatesGo to article: B&W Tek | Company InsightGo to article: B&W TekGo to article: EventsGo to article: CG ChemikalienGo to article: AlpexGo to article: Next issueGo to article: Pall Biotech Company InsightGo to article: CrewpharmGo to article: EndocaGo to article: Diversey